USANA Health Sciences, Inc. (USNA): Business Model Canvas [Apr-2026 Updated]

You're looking at USANA Health Sciences, Inc.'s (USNA) strategy, and honestly, what stands out is how they are balancing two very different businesses to hit a projected consolidated net sales of $920 million to $1.0 billion for fiscal year 2025. As someone who's spent two decades dissecting these models, the real story isn't just the core direct selling engine; it's the calculated integration of the high-growth, subscription-based children's wellness brand, Hiya, which is expected to bring in $145 million to $160 million alone. This dual-channel approach-marrying the high-touch network of Brand Partners with a modern direct-to-consumer e-commerce play-is the key to understanding their current valuation and near-term operational focus, so let's break down the nine building blocks below to see exactly how they're making this work.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Key Partnerships

You're looking at the critical external relationships USANA Health Sciences, Inc. relies on to execute its strategy as of late 2025. These aren't just names on a letterhead; they represent real financial impact and scientific validation.

Majority ownership (78.8%) of Hiya Health Products, LLC.

The acquisition of a controlling stake in Hiya Health Products, LLC, closed on December 23, 2024, for a $205 million cash transaction. USANA Health Sciences, Inc. holds a 78.8% ownership stake, with a 21.15% noncontrolling interest remaining. This move diversifies distribution channels. For the 12 months ending September 30, 2024, Hiya generated net sales of $103 million, net income of $19 million, and adjusted EBITDA of $22 million. For the full fiscal year 2025, USANA Health Sciences, Inc. anticipates Hiya net sales to fall between $145 million and $160 million, representing year-over-year growth of +29% to +42%. In the third quarter of 2025, Hiya contributed $31 million in net sales and reported 193,400 active subscribers.

Collaborations with scientific research institutions for product validation.

USANA Health Sciences, Inc. maintains relationships with several institutions to support its science-based product development. The company's R&D team works with experts in human nutrition, cellular biology, and genetics.

• University of Washington
• University of Texas Medical Branch, Galveston, Texas
• University of Utah
• The Foods for Health Institute at the University of California, Davis
• The University of North Carolina at Pembroke
• Beijing University of Chinese Medicine (BUCM)
• National Sports Training Bureau

Strategic raw material suppliers for consistent product quality.

USANA Health Sciences, Inc. relies on strategic raw material suppliers to maintain the purity and consistency of its products. The company's staff scientists are dedicated to the manufacturing and quality control processes.

Sponsorships with elite athletes and teams, like the Jamaica Bobsled Team.

The partnership with the Jamaica Bobsleigh and Skeleton Federation (JBSF) was extended in December 2025 to run through two additional Olympic cycles. The initial agreement started in early 2024. The JBSF has a history of fueling athletes to over 276 Olympic and Para-Olympic medals and 617 World titles. The USANA logo placement is featured on the team's bobsled, helmets, and racing suits.

Partnership with Disney for branded Hiya multivitamin packs.

The structure involves leveraging Hiya's expertise in children's products within USANA Health Sciences, Inc.'s channels.

Finance: draft 13-week cash view by Friday.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Key Activities

You're looking at the core actions USANA Health Sciences, Inc. takes to run its global operation as of late 2025. It's a mix of making things, selling things through people, and building new things for the future.

Manufacturing nutritional and personal care products in-house

USANA Health Sciences, Inc. maintains its own manufacturing footprint, specifically with facilities in the United States and mainland China, which helps manage the supply chain. The company reported a Gross Profit margin of 81.13% in Q1 2025. For the full fiscal year 2024, Gross Profit reached $693.3 million. Management noted an increase in inventories, which was attributed in part to new product introductions and increased investment in inventory location to support tariff mitigation efforts. The company anticipates improving margins by moving the manufacturing of its acquired Hiya products in-house, expecting this to start in late Q2 2026.

Global execution of the direct selling model and Brand Partner support

The company is executing a global strategy centered on its direct selling force, which it now terms 'Brand Partners'. USANA Health Sciences rolled out an enhanced compensation plan in the third quarter of 2025, with full launch scheduled for October 2025. This new structure includes a 10% sales bonus on the first six months of purchases for Brand Partners. In Q2 2025, the direct selling segment had Active Customers totaling 418,000, down from 468,000 in Q2 2024. For that same Q2 2025 period, Brand Partner Incentives for the direct selling segment were 43.1% of segment net sales. Mainland China was the largest direct selling market, accounting for approximately 48.4% of 2024 net sales.

Research and Development (R&D) for science-backed product innovation

USANA Health Sciences, Inc. continues to invest in R&D to support product innovation. The company allocated approximately $25 million to research and development in fiscal year 2024. The 2024 sustainability report also noted an investment of $11.6 million in R&D.

Managing the direct-to-consumer (DTC) subscription business (Hiya)

Managing the DTC subscription business, Hiya, is a key activity, with the business showing strong growth momentum. The company expects Hiya net sales for the full fiscal year 2025 to be between $145 million and $160 million. The year-to-date sales growth for Hiya, as of Q3 2025, was 26%. Here's a look at the subscriber base over the first three quarters of 2025:

Hiya's Q1 2025 performance included strong product adoption for its Kids Daily Greens + Superfoods.

Global cost reduction and operational efficiency initiatives

Operational efficiency is being pursued through integration efforts, including a transition to a new logistics partner and the implementation of a new ERP system for the acquired DTC businesses. The company initiated a global cost reduction process, which included workforce rightsizing, with an expected one-time charge of $4.7 million in Q4 2025. The balance sheet remains strong, with USANA Health Sciences, Inc. ending Q3 2025 with $145 million in cash and cash equivalents and no debt. This followed an ending cash position of $151 million with zero debt at the end of Q2 2025. Inventories stood at $86 million as of June 28, 2025.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Key Resources

Proprietary manufacturing facility in Salt Lake City, Utah.

USANA Health Sciences, Inc. conducts manufacturing, production, and quality control operations for roughly two-thirds of its nutritional products in-house, which accounts for approximately 67% of its product sales. The Salt Lake City, Utah facility is FDA-registered and GMP certified by USP and NSF. The manufacturing line includes seven high-speed tablet presses; two of these presses can produce anywhere from 60,000 to 500,000 tablets per hour.

Global network of Brand Partners (direct sales force).

As of the third quarter of 2025, the number of Direct selling Active Customers stood at 388,000. USANA Health Sciences, Inc. has operations in 25 geographic markets worldwide. The company rolled out an enhanced compensation plan that fully launched in October 2025. This new plan includes a new Sales Bonus of 10% on Brand Partners' and customers' first six months of purchases.

Strong cash position of $145 million as of Q3 2025, with no debt.

The Company ended the third quarter of 2025 with $145 million in cash and cash equivalents and reported no debt. The gross profit margin was reported at 79.18%.

Here are some key financial and operational metrics as of late 2025:

Intellectual property and science-backed product formulations.

USANA Health Sciences, Inc. is committed to continuous product innovation and sound scientific research. The company's USANA Essentials were tested in a ConsumerLab.com Multivitamin and Multimineral Supplements Review that included 38 leading multivitamin/multimineral products sold in the U.S. and Canada.

Hiya's established direct-to-consumer e-commerce platform.

The Hiya business reported 26% year-to-date sales growth as of Q3 2025. Hiya net sales in Q3 2025 were $31 million, with 193,400 active monthly subscribers. Management anticipates Hiya will generate double-digit sales growth for the full year 2025. The company anticipates beginning the manufacturing of Hiya products in-house over the next several months, expecting margin improvement in the late second quarter and back half of 2026.

• The company has plans to cross-sell Hiya products into its direct-selling network.
• The Hiya acquisition involved an initial cash investment of approximately $205 million for a 78.8% ownership stake.
• The Hiya business is expected to generate annualized operating cost savings from in-house manufacturing starting in late Q2 2026.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Value Propositions

High-quality, science-based nutritional and personal care products.

• The maximum-strength Vitamin D supplement earned the ConsumerLab.com Seal of Approval on October 16, 2025, for potency, purity, and label accuracy.
• The Vitamin D tablet delivers 50 mcg (2,000 IU) of vitamin D3 per dose and includes vitamin K.
• Testing for the Seal of Approval required meeting 100% of claimed ingredient amounts plus proper disintegration and bioavailability.
• The MagneCal D supplement also earned the ConsumerLab.com Seal of Approval, requiring it to deliver 100% of the claimed amounts of magnesium, calcium, vitamin D, and boron.
• USANA Health Sciences, Inc. reported a gross margin of 81.13% in Q1 2025, showing strong operational efficiency.

Flexible income opportunity via the enhanced Brand Partner compensation plan.

• The enhanced compensation plan for USANA Health Sciences, Inc. Brand Partners fully launched in October 2025.
• The plan includes a new Sales Bonus of 10% on Brand Partners' and customers' purchases for the first six months.
• There are three new Milestone Bonuses designed to create early success for new Brand Partners.
• The overall USANA payout rate remains unchanged at 42%.
• The company has adopted the terminology Brand Partner to describe members of its direct sales business.

Convenient, subscription-based children's wellness products (Hiya).

The direct-to-consumer business, Hiya, is a key driver of growth and diversification for USANA Health Sciences, Inc.

The projected net sales for Hiya in fiscal year 2025 represent a year-over-year growth anticipation of 29% to 42%.

Personalized customer experience and support from Brand Partners.

• The commercial strategy is positioned to improve the value proposition by delivering a more tailored experience based on better understanding specific Brand Partner and customer needs in each market.
• The company is focused on providing improved personalized business support for its Brand Partners.

Product quality assurance (e.g., ConsumerLab.com seals).

• Third-party validation, such as the ConsumerLab.com Seal of Approval, is presented as a reflection of USANA Health Sciences, Inc.'s dedication to transparency, quality, and precision.
• The company frames certifications as validation of its manufacturing, third-party testing, and evidence-based product standards.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Customer Relationships

The customer relationships for USANA Health Sciences, Inc. are bifurcated, heavily relying on the high-touch, personalized engagement of its Brand Partner network for the core direct selling business, and an automated, recurring model for its acquired Hiya direct-to-consumer segment.

Personalized support and training for Brand Partners

The relationship with Brand Partners is undergoing a significant structural update, designed to foster engagement and long-term commitment. The company collaborated with over 50 experienced USANA Brand Partners across markets to guide the strategy for these changes.

• Enhanced compensation plan fully launches in October 2025.
• New Sales Bonus awards 10% on first six months of purchases.
• Introduced three new Milestone Bonuses for new partners.

The direct selling segment saw its active customer count decline to 388,000 in Q3 2025, down from 452,000 in Q3 2024, underscoring the need for these support enhancements to drive retention.

High-touch, direct interaction through the Brand Partner network

The interaction model is inherently personal, driven by the sales force. The company is investing in better incentives to support this network. In Q3 2025, Brand Partner Incentives increased by 60 basis points year-over-year, reaching 43.1% of segment net sales. Conversely, SG&A expenses for the direct selling business increased by 150 basis points to 31.7% of segment net sales in the same period.

The company held a Global Convention in Salt Lake City to train Brand Partners on the updated compensation plan.

Automated, recurring subscription management for Hiya customers

The relationship with Hiya customers is primarily managed through a direct-to-consumer subscription model, which inherently drives recurring revenue. This segment is a key growth driver, projected to contribute between $145 million and $160 million in fiscal year 2025 net sales.

Subscriber numbers for this automated channel show significant scale:

• Reported 224,000 active monthly subscribers in Q1 2025.
• Reported 200,400 active monthly subscribers in Q2 2025.
• Generated $34 million in sales in Q2 2025.

This model is designed for high retention, complementing the traditional direct selling base which stood at approximately 454,000 active customers at the end of 2024.

Loyalty programs to drive repeat purchases and retention

Retention for the core business is directly incentivized through the new compensation structure, which rewards sustained activity. The new 10% Sales Bonus specifically targets the first six months of purchases by both Brand Partners and their customers, aiming to create earlier success experiences and improve partner retention rates.

The Hiya subscription base itself functions as a built-in loyalty mechanism, ensuring repeat purchases automatically.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Channels

The Channels component of the USANA Health Sciences, Inc. (USNA) business model centers on a dual approach, blending a vast independent sales force with modern digital direct-to-consumer (DTC) capabilities.

Global network of independent Brand Partners (direct sales)

The core channel remains the direct sales force, recently rebranded from distributors/associates to Brand Partners. This network is crucial for product movement and customer acquisition globally.

The active customer base within this channel shows recent fluctuations:

• Direct selling Active Customers as of Q2 2025: 418,000.
• Direct selling Active Customers as of Q1 2025: 459,000.
• Active Customers at the end of FY 2024: approximately 454,000.
• Active Customers as of Q2 2024: 468,000.

The company is actively modernizing this channel with an enhanced compensation plan launching in October 2025. Key incentives include:

• New Sales Bonus: 10% of Brand Partners' and customers' first six months of purchases.
• Overall USANA payout rate remains unchanged at 42%.

Company-owned e-commerce websites and digital platforms

USANA Health Sciences, Inc. is enhancing its digital infrastructure to support the Brand Partner network. This includes the launch of new back office and mobile tools designed to give Brand Partners data-driven insights for managing their business and customer outreach.

Direct-to-Consumer (DTC) subscription model for Hiya products

The acquisition of Hiya Health Products provides a significant, high-growth DTC channel built on a subscription basis. This segment is showing strong momentum in 2025.

Here is a look at the performance metrics for the Hiya DTC channel through the first three quarters of 2025:

The full-year projection for this channel is substantial, indicating its growing importance to the overall revenue mix.

• Projected FY 2025 Net Sales Contribution: $145 million to $160 million.
• This projected range represents year-over-year growth of 29% to 42%.

Global distribution and logistics network across 25 markets

USANA Health Sciences, Inc. distributes its products across a global footprint, which as of the search data, includes 25 geographic markets. The distribution relies on a logistics network that recently transitioned to a new partner for the Hiya business to drive operational efficiency. Regional sales performance highlights the concentration of the direct selling channel.

Net Sales by Region for the full year 2024 and Q3 2025:

Finance: review Q3 2025 regional sales against FY 2024 percentages to project Q4 logistics needs by end of week.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Customer Segments

You're looking at the core groups USANA Health Sciences, Inc. serves, which are segmented across its direct selling network and its direct-to-consumer (DTC) arm.

Brand Partners (Associates) form the foundation of the direct selling channel, seeking the business and income opportunity USANA Health Sciences, Inc. provides. Management has been actively training and supporting these individuals following the global rollout of an enhanced compensation plan designed to modernize the business and improve early earnings potential for entrepreneurs. This group is key to driving sales activity across international markets.

The Direct Selling Active Customers base saw a contraction through the third quarter of 2025. The consolidated count stood at approximately 388,000 active customers as of Q3 2025, representing a year-over-year decline of 14%.

Here's a quick look at the key customer metrics as reported for the third quarter of 2025:

Health-conscious consumers represent a significant portion of the customer base, with the Asia Pacific region being the largest market by revenue generation. In Q3 2025, this region brought in $140 million in net sales, though specific regional performance showed softness, with Southeast Asia Pacific sales down 22% year-over-year.

The DTC segment is anchored by the Hiya business, which targets parents of young children with its clean-label products. This segment reported 193,400 active monthly subscribers in Q3 2025, contributing $31 million in net sales for that quarter, and management expects continued double-digit sales growth for the full year 2025.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Cost Structure

You're looking at the cost side of the USANA Health Sciences, Inc. (USNA) model as of late 2025. This structure is heavily weighted toward variable compensation, but recent operational shifts are showing significant pressure on fixed and semi-fixed costs.

Brand Partner compensation and incentives (variable cost)

The cost associated with the Brand Partner network is a primary variable expense. USANA Health Sciences, Inc. fully launched an enhanced compensation plan in October 2025, designed to reward early engagement and retention. The key components of this variable payout structure include:

• New sales bonus of 10% on first six months of purchases.
• Three new Milestone Bonuses for early success.
• Enhanced leadership bonuses for sustainable growth.

The rollout of this new plan in Q3 2025 coincided with a pronounced productivity slowdown among Brand Partners, which directly impacted the cost efficiency of sales generation.

Manufacturing and raw material costs (Cost of Goods Sold)

Costs here are tied to product creation and inventory management. USANA Health Sciences, Inc. noted an increase in inventories in Q3 2025, driven by new product introductions and strategic investments to mitigate tariffs. The company is actively working to improve future margins by bringing manufacturing in-house for its acquired DTC brand, Hiya, with expected margin improvement beginning in the late second quarter of 2026.

Sales, General, and Administrative (SG&A) expenses, including marketing

This category showed severe strain in the third quarter of 2025. Operating costs relative to sales ballooned due to the compensation plan transition and other factors. Here's a quick look at the Q3 2025 operational cost impact compared to the prior year:

The income tax expense was particularly high, totaling $8.5 million on only $1.8 million in pretax earnings for Q3 2025, reflecting a substantial increase in the effective tax rate.

Research and Development (R&D) investment

The ability to invest in R&D to innovate and increase the cadence of new product releases is a key operational factor. Specific R&D spending figures for the 2025 fiscal year are not yet public, but the company's strategy relies on this investment to support growth initiatives across its core and acquired businesses.

One-time restructuring charge of $4.7 million expected in Q4 2025

As part of a global cost reduction and workforce rightsizing initiative announced in Q3 2025, USANA Health Sciences, Inc. anticipates incurring a one-time charge of $4.7 million in the fourth quarter of 2025. Finance: draft 13-week cash view by Friday.

USANA Health Sciences, Inc. (USNA) - Canvas Business Model: Revenue Streams

You're looking at the top-line drivers for USANA Health Sciences, Inc. as we map out the late 2025 view. The revenue streams are clearly bifurcated between the established direct selling network and the growing direct-to-consumer (DTC) channel via the Hiya acquisition.

Here is the quick math on the key projected revenue components for the full fiscal year 2025:

The primary engine remains the core direct selling business. This segment is projected to generate net sales between $775 million and $840 million for fiscal year 2025. This range reflects an anticipated growth of 8% to 17% in consolidated net sales year-over-year, though the direct selling component itself is navigating changes, including the rollout of an enhanced Brand Partner compensation plan.

The second major stream comes from the direct-to-consumer channel, specifically the Hiya business. For fiscal year 2025, Hiya's net sales are anticipated to range between $145 million and $160 million. This represents a robust year-over-year growth projection of 29% to 42% for the Hiya segment alone.

The nature of sales within the direct selling structure involves:

• Product sales to Brand Partners.
• Product sales to Preferred Customers.

The Hiya revenue model is heavily reliant on recurring purchases, which translates to subscription revenue. As of the third quarter of 2025, Hiya reported 193,400 active subscribers, following a Q2 figure of 200,400 Active Monthly Subscribers. The Kids Daily Greens product is noted as a strong performer within this subscription base.

Overall, USANA Health Sciences, Inc. projects its consolidated net sales for fiscal year 2025 to fall between $920 million and $1.0 billion.